1 Study Coverage 1.1 Hemophilia A Drug Product Introduction 1.2 Market by Type 1.2.1 Global Hemophilia A Drug Market Size Growth Rate by Type 1.4.2 ATXF-8117 1.4.3 BAY-1093884 1.2.4 BIVV-001 1.2.5 BS-027125 1.2.6 Concizumab 1.2.7 CSL-689 1.2.8 Others 1.3 Market by Application 1.3.1 Global Hemophilia A Drug Market Size Growth Rate by Application 1.3.2 Clinic 1.3.3 Hospital 1.3.4 ASCs 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Hemophilia A Drug Sales Estimates and Forecasts 2016-2027 2.2 Global Hemophilia A Drug Revenue Estimates and Forecasts 2016-2027 2.3 Global Hemophilia A Drug Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Hemophilia A Drug Regions by Sales 2.4.1 Global Top Hemophilia A Drug Regions by Sales (2016-2021) 2.4.2 Global Top Hemophilia A Drug Regions by Sales (2022-2027) 2.5 Global Top Hemophilia A Drug Regions by Revenue 2.5.1 Global Top Hemophilia A Drug Regions by Revenue (2016-2021) 2.5.2 Global Top Hemophilia A Drug Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Hemophilia A Drug Sales by Manufacturers 3.1.1 Global Top Hemophilia A Drug Manufacturers by Sales (2016-2021) 3.1.2 Global Top Hemophilia A Drug Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Hemophilia A Drug Sales in 2020 3.2 Global Hemophilia A Drug Revenue by Manufacturers 3.2.1 Global Top Hemophilia A Drug Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Hemophilia A Drug Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Hemophilia A Drug Revenue in 2020 3.3 Global Hemophilia A Drug Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Hemophilia A Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Hemophilia A Drug Sales by Type 4.1.1 Global Hemophilia A Drug Historical Sales by Type (2016-2021) 4.1.2 Global Hemophilia A Drug Forecasted Sales by Type (2022-2027) 4.1.3 Global Hemophilia A Drug Sales Market Share by Type (2016-2027) 4.2 Global Hemophilia A Drug Revenue by Type 4.2.1 Global Hemophilia A Drug Historical Revenue by Type (2016-2021) 4.2.2 Global Hemophilia A Drug Forecasted Revenue by Type (2022-2027) 4.2.3 Global Hemophilia A Drug Revenue Market Share by Type (2016-2027) 4.3 Global Hemophilia A Drug Price by Type 4.3.1 Global Hemophilia A Drug Price by Type (2016-2021) 4.3.2 Global Hemophilia A Drug Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Hemophilia A Drug Sales by Application 5.1.1 Global Hemophilia A Drug Historical Sales by Application (2016-2021) 5.1.2 Global Hemophilia A Drug Forecasted Sales by Application (2022-2027) 5.1.3 Global Hemophilia A Drug Sales Market Share by Application (2016-2027) 5.2 Global Hemophilia A Drug Revenue by Application 5.2.1 Global Hemophilia A Drug Historical Revenue by Application (2016-2021) 5.2.2 Global Hemophilia A Drug Forecasted Revenue by Application (2022-2027) 5.2.3 Global Hemophilia A Drug Revenue Market Share by Application (2016-2027) 5.3 Global Hemophilia A Drug Price by Application 5.3.1 Global Hemophilia A Drug Price by Application (2016-2021) 5.3.2 Global Hemophilia A Drug Price Forecast by Application (2022-2027) 6 North America 6.1 North America Hemophilia A Drug Market Size by Type 6.1.1 North America Hemophilia A Drug Sales by Type (2016-2027) 6.1.2 North America Hemophilia A Drug Revenue by Type (2016-2027) 6.2 North America Hemophilia A Drug Market Size by Application 6.2.1 North America Hemophilia A Drug Sales by Application (2016-2027) 6.2.2 North America Hemophilia A Drug Revenue by Application (2016-2027) 6.3 North America Hemophilia A Drug Market Size by Country 6.3.1 North America Hemophilia A Drug Sales by Country (2016-2027) 6.3.2 North America Hemophilia A Drug Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Hemophilia A Drug Market Size by Type 7.1.1 Europe Hemophilia A Drug Sales by Type (2017-2027) 7.1.2 Europe Hemophilia A Drug Revenue by Type (2017-2027) 7.2 Europe Hemophilia A Drug Market Size by Application 7.2.1 Europe Hemophilia A Drug Sales by Application (2017-2027) 7.2.2 Europe Hemophilia A Drug Revenue by Application (2017-2027) 7.3 Europe Hemophilia A Drug Market Size by Country 7.3.1 Europe Hemophilia A Drug Sales by Country (2017-2027) 7.3.2 Europe Hemophilia A Drug Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Hemophilia A Drug Market Size by Type 8.1.1 Asia Pacific Hemophilia A Drug Sales by Type (2018-2027) 8.1.2 Asia Pacific Hemophilia A Drug Revenue by Type (2018-2027) 8.2 Asia Pacific Hemophilia A Drug Market Size by Application 8.2.1 Asia Pacific Hemophilia A Drug Sales by Application (2018-2027) 8.2.2 Asia Pacific Hemophilia A Drug Revenue by Application (2018-2027) 8.3 Asia Pacific Hemophilia A Drug Market Size by Region 8.3.1 Asia Pacific Hemophilia A Drug Sales by Region (2018-2027) 8.3.2 Asia Pacific Hemophilia A Drug Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Hemophilia A Drug Market Size by Type 9.1.1 Latin America Hemophilia A Drug Sales by Type (2019-2027) 9.1.2 Latin America Hemophilia A Drug Revenue by Type (2019-2027) 9.2 Latin America Hemophilia A Drug Market Size by Application 9.2.1 Latin America Hemophilia A Drug Sales by Application (2019-2027) 9.2.2 Latin America Hemophilia A Drug Revenue by Application (2019-2027) 9.3 Latin America Hemophilia A Drug Market Size by Country 9.3.1 Latin America Hemophilia A Drug Sales by Country (2019-2027) 9.3.2 Latin America Hemophilia A Drug Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Hemophilia A Drug Market Size by Type 6.1.1 Middle East and Africa Hemophilia A Drug Sales by Type (2016-2027) 6.1.2 Middle East and Africa Hemophilia A Drug Revenue by Type (2016-2027) 6.2 Middle East and Africa Hemophilia A Drug Market Size by Application 6.2.1 Middle East and Africa Hemophilia A Drug Sales by Application (2016-2027) 6.2.2 Middle East and Africa Hemophilia A Drug Revenue by Application (2016-2027) 6.3 Middle East and Africa Hemophilia A Drug Market Size by Country 6.3.1 Middle East and Africa Hemophilia A Drug Sales by Country (2016-2027) 6.3.2 Middle East and Africa Hemophilia A Drug Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Bayer AG 11.1.1 Bayer AG Corporation Information 11.1.2 Bayer AG Overview 11.1.3 Bayer AG Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Bayer AG Hemophilia A Drug Product Description 11.1.5 Bayer AG Related Developments 11.2 BioMarin Pharmaceutical Inc 11.2.1 BioMarin Pharmaceutical Inc Corporation Information 11.2.2 BioMarin Pharmaceutical Inc Overview 11.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 BioMarin Pharmaceutical Inc Hemophilia A Drug Product Description 11.2.5 BioMarin Pharmaceutical Inc Related Developments 11.3 Bioverativ Inc 11.3.1 Bioverativ Inc Corporation Information 11.3.2 Bioverativ Inc Overview 11.3.3 Bioverativ Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Bioverativ Inc Hemophilia A Drug Product Description 11.3.5 Bioverativ Inc Related Developments 11.4 Catalyst Biosciences Inc 11.4.1 Catalyst Biosciences Inc Corporation Information 11.4.2 Catalyst Biosciences Inc Overview 11.4.3 Catalyst Biosciences Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Catalyst Biosciences Inc Hemophilia A Drug Product Description 11.4.5 Catalyst Biosciences Inc Related Developments 11.5 Chugai Pharmaceutical Co Ltd 11.5.1 Chugai Pharmaceutical Co Ltd Corporation Information 11.5.2 Chugai Pharmaceutical Co Ltd Overview 11.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Description 11.5.5 Chugai Pharmaceutical Co Ltd Related Developments 11.6 CSL Ltd 11.6.1 CSL Ltd Corporation Information 11.6.2 CSL Ltd Overview 11.6.3 CSL Ltd Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 CSL Ltd Hemophilia A Drug Product Description 11.6.5 CSL Ltd Related Developments 11.7 DBV Technologies SA 11.7.1 DBV Technologies SA Corporation Information 11.7.2 DBV Technologies SA Overview 11.7.3 DBV Technologies SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 DBV Technologies SA Hemophilia A Drug Product Description 11.7.5 DBV Technologies SA Related Developments 11.8 Dimension Therapeutics Inc 11.8.1 Dimension Therapeutics Inc Corporation Information 11.8.2 Dimension Therapeutics Inc Overview 11.8.3 Dimension Therapeutics Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Dimension Therapeutics Inc Hemophilia A Drug Product Description 11.8.5 Dimension Therapeutics Inc Related Developments 11.9 EpiVax Inc 11.9.1 EpiVax Inc Corporation Information 11.9.2 EpiVax Inc Overview 11.9.3 EpiVax Inc Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 EpiVax Inc Hemophilia A Drug Product Description 11.9.5 EpiVax Inc Related Developments 11.10 Expression Therapeutics LLC 11.10.1 Expression Therapeutics LLC Corporation Information 11.10.2 Expression Therapeutics LLC Overview 11.10.3 Expression Therapeutics LLC Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Expression Therapeutics LLC Hemophilia A Drug Product Description 11.10.5 Expression Therapeutics LLC Related Developments 11.1 Bayer AG 11.1.1 Bayer AG Corporation Information 11.1.2 Bayer AG Overview 11.1.3 Bayer AG Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Bayer AG Hemophilia A Drug Product Description 11.1.5 Bayer AG Related Developments 11.12 Idogen AB 11.12.1 Idogen AB Corporation Information 11.12.2 Idogen AB Overview 11.12.3 Idogen AB Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Idogen AB Product Description 11.12.5 Idogen AB Related Developments 11.13 Immusoft Corp 11.13.1 Immusoft Corp Corporation Information 11.13.2 Immusoft Corp Overview 11.13.3 Immusoft Corp Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Immusoft Corp Product Description 11.13.5 Immusoft Corp Related Developments 11.14 LFB SA 11.14.1 LFB SA Corporation Information 11.14.2 LFB SA Overview 11.14.3 LFB SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.14.4 LFB SA Product Description 11.14.5 LFB SA Related Developments 11.15 mAbxience SA 11.15.1 mAbxience SA Corporation Information 11.15.2 mAbxience SA Overview 11.15.3 mAbxience SA Hemophilia A Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.15.4 mAbxience SA Product Description 11.15.5 mAbxience SA Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Hemophilia A Drug Value Chain Analysis 12.2 Hemophilia A Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Hemophilia A Drug Production Mode & Process 12.4 Hemophilia A Drug Sales and Marketing 12.4.1 Hemophilia A Drug Sales Channels 12.4.2 Hemophilia A Drug Distributors 12.5 Hemophilia A Drug Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Hemophilia A Drug Industry Trends 13.2 Hemophilia A Drug Market Drivers 13.3 Hemophilia A Drug Market Challenges 13.4 Hemophilia A Drug Market Restraints 14 Key Findings in The Global Hemophilia A Drug Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Hemophilia A Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of ATXF-8117 Table 3. Major Manufacturers of BAY-1093884 Table 4. Major Manufacturers of BIVV-001 Table 5. Major Manufacturers of BS-027125 Table 6. Major Manufacturers of Concizumab Table 7. Major Manufacturers of CSL-689 Table 8. Major Manufacturers of Others Table 9. Global Hemophilia A Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 10. Global Hemophilia A Drug Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 11. Global Hemophilia A Drug Sales by Region (2016-2021) & (K Pcs) Table 12. Global Hemophilia A Drug Sales Market Share by Region (2016-2021) Table 13. Global Hemophilia A Drug Sales by Region (2016-2021) & (K Pcs) Table 14. Global Hemophilia A Drug Sales Market Share by Region (2022-2027) Table 15. Global Hemophilia A Drug Revenue by Region (2016-2021) & (US$ Million) Table 16. Global Hemophilia A Drug Revenue Market Share by Region (2016-2021) Table 17. Global Hemophilia A Drug Revenue by Region (2022-2027) & (US$ Million) Table 18. Global Hemophilia A Drug Revenue Market Share by Region (2022-2027) Table 19. Global Hemophilia A Drug Sales by Manufacturers (2016-2021) & (K Pcs) Table 20. Global Hemophilia A Drug Sales Share by Manufacturers (2016-2021) Table 21. Global Hemophilia A Drug Revenue by Manufacturers (2016-2021) & (US$ Million) Table 22. Global Hemophilia A Drug Revenue Share by Manufacturers (2016-2021) Table 23. Hemophilia A Drug Price by Manufacturers 2016-2021 (USD/Pcs) Table 24. Global Hemophilia A Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 25. Global Hemophilia A Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia A Drug as of 2020) Table 26. Hemophilia A Drug Manufacturing Base Distribution and Headquarters Table 27. Manufacturers Hemophilia A Drug Product Offered Table 28. Date of Manufacturers Enter into Hemophilia A Drug Market Table 29. Mergers & Acquisitions, Expansion Plans Table 30. Global Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs) Table 31. Global Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs) Table 32. Global Hemophilia A Drug Sales Share by Type (2016-2021) Table 33. Global Hemophilia A Drug Sales Share by Type (2022-2027) Table 34. Global Hemophilia A Drug Revenue by Type (2016-2021) & (US$ Million) Table 35. Global Hemophilia A Drug Revenue by Type (2022-2027) & (US$ Million) Table 36. Global Hemophilia A Drug Revenue Share by Type (2016-2021) Table 37. Global Hemophilia A Drug Revenue Share by Type (2022-2027) Table 38. Hemophilia A Drug Price by Type (2016-2021) & (USD/Pcs) Table 39. Global Hemophilia A Drug Price Forecast by Type (2022-2027) & (USD/Pcs) Table 40. Global Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs) Table 41. Global Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs) Table 42. Global Hemophilia A Drug Sales Share by Application (2016-2021) Table 43. Global Hemophilia A Drug Sales Share by Application (2022-2027) Table 44. Global Hemophilia A Drug Revenue by Application (2016-2021) & (US$ Million) Table 45. Global Hemophilia A Drug Revenue by Application (2022-2027) & (US$ Million) Table 46. Global Hemophilia A Drug Revenue Share by Application (2016-2021) Table 47. Global Hemophilia A Drug Revenue Share by Application (2022-2027) Table 48. Hemophilia A Drug Price by Application (2016-2021) & (USD/Pcs) Table 49. Global Hemophilia A Drug Price Forecast by Application (2022-2027) & (USD/Pcs) Table 50. North America Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs) Table 51. North America Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs) Table 52. North America Hemophilia A Drug Revenue by Type (2016-2021) & (US$ Million) Table 53. North America Hemophilia A Drug Revenue by Type (2022-2027) & (US$ Million) Table 54. North America Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs) Table 55. North America Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs) Table 56. North America Hemophilia A Drug Revenue by Application (2016-2021) & (US$ Million) Table 57. North America Hemophilia A Drug Revenue by Application (2022-2027) & (US$ Million) Table 58. North America Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs) Table 59. North America Hemophilia A Drug Sales by Country (2022-2027) & (K Pcs) Table 60. North America Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million) Table 61. North America Hemophilia A Drug Revenue by Country (2022-2027) & (US$ Million) Table 62. Europe Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs) Table 63. Europe Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs) Table 64. Europe Hemophilia A Drug Revenue by Type (2016-2021) & (US$ Million) Table 65. Europe Hemophilia A Drug Revenue by Type (2022-2027) & (US$ Million) Table 66. Europe Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs) Table 67. Europe Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs) Table 68. Europe Hemophilia A Drug Revenue by Application (2016-2021) & (US$ Million) Table 69. Europe Hemophilia A Drug Revenue by Application (2022-2027) & (US$ Million) Table 70. Europe Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs) Table 71. Europe Hemophilia A Drug Sales by Country (2022-2027) & (K Pcs) Table 72. Europe Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million) Table 73. Europe Hemophilia A Drug Revenue by Country (2022-2027) & (US$ Million) Table 74. Asia Pacific Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs) Table 75. Asia Pacific Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs) Table 76. Asia Pacific Hemophilia A Drug Revenue by Type (2016-2021) & (US$ Million) Table 77. Asia Pacific Hemophilia A Drug Revenue by Type (2022-2027) & (US$ Million) Table 78. Asia Pacific Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs) Table 79. Asia Pacific Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs) Table 80. Asia Pacific Hemophilia A Drug Revenue by Application (2016-2021) & (US$ Million) Table 81. Asia Pacific Hemophilia A Drug Revenue by Application (2022-2027) & (US$ Million) Table 82. Asia Pacific Hemophilia A Drug Sales by Region (2016-2021) & (K Pcs) Table 83. Asia Pacific Hemophilia A Drug Sales by Region (2022-2027) & (K Pcs) Table 84. Asia Pacific Hemophilia A Drug Revenue by Region (2016-2021) & (US$ Million) Table 85. Asia Pacific Hemophilia A Drug Revenue by Region (2022-2027) & (US$ Million) Table 86. Latin America Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs) Table 87. Latin America Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs) Table 88. Latin America Hemophilia A Drug Revenue by Type (2016-2021) & (US$ Million) Table 89. Latin America Hemophilia A Drug Revenue by Type (2022-2027) & (US$ Million) Table 90. Latin America Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs) Table 91. Latin America Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs) Table 92. Latin America Hemophilia A Drug Revenue by Application (2016-2021) & (US$ Million) Table 93. Latin America Hemophilia A Drug Revenue by Application (2022-2027) & (US$ Million) Table 94. Latin America Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs) Table 95. Latin America Hemophilia A Drug Sales by Country (2022-2027) & (K Pcs) Table 96. Latin America Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million) Table 97. Latin America Hemophilia A Drug Revenue by Country (2022-2027) & (US$ Million) Table 98. Middle East and Africa Hemophilia A Drug Sales by Type (2016-2021) & (K Pcs) Table 99. Middle East and Africa Hemophilia A Drug Sales by Type (2022-2027) & (K Pcs) Table 100. Middle East and Africa Hemophilia A Drug Revenue by Type (2016-2021) & (US$ Million) Table 101. Middle East and Africa Hemophilia A Drug Revenue by Type (2022-2027) & (US$ Million) Table 102. Middle East and Africa Hemophilia A Drug Sales by Application (2016-2021) & (K Pcs) Table 103. Middle East and Africa Hemophilia A Drug Sales by Application (2022-2027) & (K Pcs) Table 104. Middle East and Africa Hemophilia A Drug Revenue by Application (2016-2021) & (US$ Million) Table 105. Middle East and Africa Hemophilia A Drug Revenue by Application (2022-2027) & (US$ Million) Table 106. Middle East and Africa Hemophilia A Drug Sales by Country (2016-2021) & (K Pcs) Table 107. Middle East and Africa Hemophilia A Drug Sales by Country (2022-2027) & (K Pcs) Table 108. Middle East and Africa Hemophilia A Drug Revenue by Country (2016-2021) & (US$ Million) Table 109. Middle East and Africa Hemophilia A Drug Revenue by Country (2022-2027) & (US$ Million) Table 110. Bayer AG Corporation Information Table 111. Bayer AG Description and Major Businesses Table 112. Bayer AG Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 113. Bayer AG Hemophilia A Drug Product Table 114. Bayer AG Recent Developments Table 115. BioMarin Pharmaceutical Inc Corporation Information Table 116. BioMarin Pharmaceutical Inc Description and Major Businesses Table 117. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 118. BioMarin Pharmaceutical Inc Hemophilia A Drug Product Table 119. BioMarin Pharmaceutical Inc Recent Developments Table 120. Bioverativ Inc Corporation Information Table 121. Bioverativ Inc Description and Major Businesses Table 122. Bioverativ Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 123. Bioverativ Inc Hemophilia A Drug Product Table 124. Bioverativ Inc Recent Developments Table 125. Catalyst Biosciences Inc Corporation Information Table 126. Catalyst Biosciences Inc Description and Major Businesses Table 127. Catalyst Biosciences Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 128. Catalyst Biosciences Inc Hemophilia A Drug Product Table 129. Catalyst Biosciences Inc Recent Developments Table 130. Chugai Pharmaceutical Co Ltd Corporation Information Table 131. Chugai Pharmaceutical Co Ltd Description and Major Businesses Table 132. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 133. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Table 134. Chugai Pharmaceutical Co Ltd Recent Developments Table 135. CSL Ltd Corporation Information Table 136. CSL Ltd Description and Major Businesses Table 137. CSL Ltd Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 138. CSL Ltd Hemophilia A Drug Product Table 139. CSL Ltd Recent Developments Table 140. DBV Technologies SA Corporation Information Table 141. DBV Technologies SA Description and Major Businesses Table 142. DBV Technologies SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 143. DBV Technologies SA Hemophilia A Drug Product Table 144. DBV Technologies SA Recent Developments Table 145. Dimension Therapeutics Inc Corporation Information Table 146. Dimension Therapeutics Inc Description and Major Businesses Table 147. Dimension Therapeutics Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 148. Dimension Therapeutics Inc Hemophilia A Drug Product Table 149. Dimension Therapeutics Inc Recent Developments Table 150. EpiVax Inc Corporation Information Table 151. EpiVax Inc Description and Major Businesses Table 152. EpiVax Inc Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 153. EpiVax Inc Hemophilia A Drug Product Table 154. EpiVax Inc Recent Developments Table 155. Expression Therapeutics LLC Corporation Information Table 156. Expression Therapeutics LLC Description and Major Businesses Table 157. Expression Therapeutics LLC Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 158. Expression Therapeutics LLC Hemophilia A Drug Product Table 159. Expression Therapeutics LLC Recent Developments Table 160. Green Cross Corp Corporation Information Table 161. Green Cross Corp Description and Major Businesses Table 162. Green Cross Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 163. Green Cross Corp Hemophilia A Drug Product Table 164. Green Cross Corp Recent Developments Table 165. Idogen AB Corporation Information Table 166. Idogen AB Description and Major Businesses Table 167. Idogen AB Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 168. Idogen AB Hemophilia A Drug Product Table 169. Idogen AB Recent Developments Table 170. Immusoft Corp Corporation Information Table 171. Immusoft Corp Description and Major Businesses Table 172. Immusoft Corp Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 173. Immusoft Corp Hemophilia A Drug Product Table 174. Immusoft Corp Recent Developments Table 175. LFB SA Corporation Information Table 176. LFB SA Description and Major Businesses Table 177. LFB SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 178. LFB SA Hemophilia A Drug Product Table 179. LFB SA Recent Developments Table 180. mAbxience SA Corporation Information Table 181. mAbxience SA Description and Major Businesses Table 182. mAbxience SA Hemophilia A Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 183. mAbxience SA Hemophilia A Drug Product Table 184. mAbxience SA Recent Developments Table 185. Key Raw Materials Lists Table 186. Raw Materials Key Suppliers Lists Table 187. Hemophilia A Drug Distributors List Table 188. Hemophilia A Drug Customers List Table 189. Hemophilia A Drug Market Trends Table 190. Hemophilia A Drug Market Drivers Table 191. Hemophilia A Drug Market Challenges Table 192. Hemophilia A Drug Market Restraints Table 193. Research Programs/Design for This Report Table 194. Key Data Information from Secondary Sources Table 195. Key Data Information from Primary Sources List of Figures Figure 1. Hemophilia A Drug Product Picture Figure 2. Global Hemophilia A Drug Market Share by Type in 2020 & 2027 Figure 3. ATXF-8117 Product Picture Figure 4. BAY-1093884 Product Picture Figure 5. BIVV-001 Product Picture Figure 6. BS-027125 Product Picture Figure 7. Concizumab Product Picture Figure 8. CSL-689 Product Picture Figure 9. Others Product Picture Figure 10. Global Hemophilia A Drug Sales Market Share by Application in 2020 & 2027 Figure 11. Clinic Figure 12. Hospital Figure 13. ASCs Figure 14. Hemophilia A Drug Report Years Considered Figure 15. Global Hemophilia A Drug Sales 2016-2027 (K Pcs) Figure 16. Global Hemophilia A Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Hemophilia A Drug Revenue 2016-2027 (US$ Million) Figure 18. Global Hemophilia A Drug Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 19. Global Hemophilia A Drug Sales Market Share by Region (2016-2021) Figure 20. Global Hemophilia A Drug Sales Market Share by Region (2022-2027) Figure 21. North America Hemophilia A Drug Sales YoY (2016-2027) & (K Pcs) Figure 22. North America Hemophilia A Drug Revenue YoY (2016-2027) & (US$ Million) Figure 23. Europe Hemophilia A Drug Sales YoY (2016-2027) & (K Pcs) Figure 24. Europe Hemophilia A Drug Revenue YoY (2016-2027) & (US$ Million) Figure 25. Asia-Pacific Hemophilia A Drug Sales YoY (2016-2027) & (K Pcs) Figure 26. Asia-Pacific Hemophilia A Drug Revenue YoY (2016-2027) & (US$ Million) Figure 27. Latin America Hemophilia A Drug Sales YoY (2016-2027) & (K Pcs) Figure 28. Latin America Hemophilia A Drug Revenue YoY (2016-2027) & (US$ Million) Figure 29. Middle East & Africa Hemophilia A Drug Sales YoY (2016-2027) & (K Pcs) Figure 30. Middle East & Africa Hemophilia A Drug Revenue YoY (2016-2027) & (US$ Million) Figure 31. The Top 10 and Top 5 Players Market Share by Hemophilia A Drug Sales in 2020 Figure 32. The Top 10 and Top 5 Players Market Share by Hemophilia A Drug Revenue in 2020 Figure 33. Hemophilia A Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 34. Global Hemophilia A Drug Sales Market Share by Type (2016-2027) Figure 35. Global Hemophilia A Drug Revenue Market Share by Type (2016-2027) Figure 36. Global Hemophilia A Drug Sales Market Share by Application (2016-2027) Figure 37. Global Hemophilia A Drug Revenue Market Share by Application (2016-2027) Figure 38. North America Hemophilia A Drug Sales Market Share by Type (2016-2027) Figure 39. North America Hemophilia A Drug Revenue Market Share by Type (2016-2027) Figure 40. North America Hemophilia A Drug Sales Market Share by Application (2016-2027) Figure 41. North America Hemophilia A Drug Revenue Market Share by Application (2016-2027) Figure 42. North America Hemophilia A Drug Sales Share by Country (2016-2027) Figure 43. North America Hemophilia A Drug Revenue Share by Country (2016-2027) Figure 44. U.S. Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 45. Canada Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 46. Europe Hemophilia A Drug Sales Market Share by Type (2016-2027) Figure 47. Europe Hemophilia A Drug Revenue Market Share by Type (2016-2027) Figure 48. Europe Hemophilia A Drug Sales Market Share by Application (2016-2027) Figure 49. Europe Hemophilia A Drug Revenue Market Share by Application (2016-2027) Figure 50. Europe Hemophilia A Drug Sales Share by Country (2016-2027) Figure 51. Europe Hemophilia A Drug Revenue Share by Country (2016-2027) Figure 52. Germany Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 53. France Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 54. U.K. Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 55. Italy Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 56. Russia Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 57. Asia Pacific Hemophilia A Drug Sales Market Share by Type (2016-2027) Figure 58. Asia Pacific Hemophilia A Drug Revenue Market Share by Type (2016-2027) Figure 59. Asia Pacific Hemophilia A Drug Sales Market Share by Application (2016-2027) Figure 60. Asia Pacific Hemophilia A Drug Revenue Market Share by Application (2016-2027) Figure 61. Asia Pacific Hemophilia A Drug Sales Share by Region (2016-2027) Figure 62. Asia Pacific Hemophilia A Drug Revenue Share by Region (2016-2027) Figure 63. China Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 64. Japan Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 65. South Korea Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 66. India Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 67. Australia Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 68. Taiwan Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 69. Indonesia Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 70. Thailand Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 71. Malaysia Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 72. Philippines Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 73. Latin America Hemophilia A Drug Sales Market Share by Type (2016-2027) Figure 74. Latin America Hemophilia A Drug Revenue Market Share by Type (2016-2027) Figure 75. Latin America Hemophilia A Drug Sales Market Share by Application (2016-2027) Figure 76. Latin America Hemophilia A Drug Revenue Market Share by Application (2016-2027) Figure 77. Latin America Hemophilia A Drug Sales Share by Country (2016-2027) Figure 78. Latin America Hemophilia A Drug Revenue Share by Country (2016-2027) Figure 79. Mexico Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 80. Brazil Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 81. Argentina Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 82. Middle East and Africa Hemophilia A Drug Sales Market Share by Type (2016-2027) Figure 83. Middle East and Africa Hemophilia A Drug Revenue Market Share by Type (2016-2027) Figure 84. Middle East and Africa Hemophilia A Drug Sales Market Share by Application (2016-2027) Figure 85. Middle East and Africa Hemophilia A Drug Revenue Market Share by Application (2016-2027) Figure 86. Middle East and Africa Hemophilia A Drug Sales Share by Country (2016-2027) Figure 87. Middle East and Africa Hemophilia A Drug Revenue Share by Country (2016-2027) Figure 88. Turkey Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 89. Saudi Arabia Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 90. U.A.E Hemophilia A Drug Revenue (2016-2027) & (US$ Million) Figure 91. Hemophilia A Drug Value Chain Figure 92. Hemophilia A Drug Production Process Figure 93. Channels of Distribution Figure 94. Distributors Profiles Figure 95. Bottom-up and Top-down Approaches for This Report Figure 96. Data Triangulation Figure 97. Key Executives Interviewed

Bayer AG BioMarin Pharmaceutical Inc Bioverativ Inc Catalyst Biosciences Inc Chugai Pharmaceutical Co Ltd CSL Ltd DBV Technologies SA Dimension Therapeutics Inc EpiVax Inc Expression Therapeutics LLC Green Cross Corp Idogen AB Immusoft Corp LFB SA mAbxience SA